Sectors
RARE
Ultragenyx Pharmaceutical Inc.
26.49
1 x 26.30
12 x 27.10
bid
ask
+
0.11
0.42%
100 @ 04:00 PM
26.80 +0.31 (1.17%)
| Ytd | 15.17% | |
| 1y | -8.69% |
25.75
day range
26.58
18.50
52 week range
36.54
| Open | 26.22 | Prev Close | 26.38 | Low | 25.75 | High | 26.58 | Mkt Cap | 2.61B |
| Vol | 1.14M | Avg Vol | 2.26M | EPS | -5.84 | P/E | -4.54 | Forward P/E | 10.06 |
| Beta | 0.31 | Short Ratio | 7.09 | Inst. Own | 110.41% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 27.92 | 200-d Avg | 26.68 | 1yr Est | 52.84 |
| Income Statement | |||
| Total Revenue | 214.00M | ||
| Revenues (USD) | 214.00M | ||
| Cost of Revenue | 34.00M | ||
| Gross Profit | 180.00M | ||
| Operating Expenses | 255.00M | ||
| Research and Development Expense | 167.00M | ||
| Selling, General and Administrative Expense | 88.00M | ||
| Operating Income | -75.00M | ||
| Income Tax Expense | 1000.00K | ||
| Net Income | -92.00M | ||
| Net Income Common Stock | -92.00M | ||
| Net Income Common Stock (USD) | -92.00M | ||
| Consolidated Income | -92.00M | ||
| Earnings per Basic Share | -0.90 | ||
| Earnings per Basic Share (USD) | -0.90 | ||
| Earnings per Diluted Share | -0.90 | ||
| Earning Before Interest & Taxes (EBIT) | -91.00M | ||
| Earning Before Interest & Taxes (USD) | -91.00M | ||
| Weighted Average Shares | 101.90M | ||
| Weighted Average Shares Diluted | 101.90M | ||
| Balance Sheet | |||
| Cash and Equivalents | 125.00M | ||
| Cash and Equivalents (USD) | 125.00M | ||
| Investments | 311.00M | ||
| Investments Current | 167.00M | ||
| Investments Non-Current | 144.00M | ||
| Trade and Non-Trade Receivables | 200.00M | ||
| Current Assets | 606.00M | ||
| Property, Plant & Equipment Net | 235.00M | ||
| Total Assets | 1.26B | ||
| Debt Current | 76.00M | ||
| Total Debt | 1.20B | ||
| Current Liabilities | 351.00M | ||
| Debt Non-Current | 1.13B | ||
| Total Liabilities | 1.55B | ||
| Accumulated Retained Earnings (Deficit) | -4.81B | ||
| Shareholders Equity | -298.00M | ||
| Shareholders Equity (USD) | -298.00M | ||
| Assets Non-Current | 658.00M | ||
| Total Debt (USD) | 1.20B | ||
| Goodwill and Intangible Assets | 216.00M | ||
| Inventory | 59.00M | ||
| Liabilities Non-Current | 1.20B | ||
| Trade and Non-Trade Payables | 39.00M | ||
| Tax Liabilities | 30.00M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 8.00M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -49.00M | ||
| Capital Expenditure | -1000.00K | ||
| Net Cash Flow from Investing | 44.00M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 48.00M | ||
| Net Cash Flow from Operations | -97.00M | ||
| Effect of Exchange Rate Changes on Cash | 1000.00K | ||
| Share Based Compensation | 34.00M | ||